
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Most loved VR Game for Wellness: Which Keeps You Dynamic? - 2
Recalled "super greens" supplement linked to dozens of salmonella cases, CDC says - 3
Merz says army could be involved in mine-clearing from Hormuz - 4
SpaceX rocket launches 140 satellites into orbit on Transporter-15, aces landing at sea (video) - 5
NASA, in a rare move, cuts space station mission short after an astronaut's medical issue
Top 20 Style Brands for Pioneers
Step by step instructions to Look at Compact disc Rates: A Thorough Aide
‘Ukrainian housewives’ and Skyranger delays – German defense poster child Rheinmetall is in hot water
Astronaut on ISS captures spectacular orbital video of zodiacal light, auroras and the Pleiades
Vote In favor of Your Number one Game Control center
Israeli strikes on Beirut, as Hezbollah and Iran attack Israel
Israel has clear objectives south of Litani River, but will face difficult choices further north
Manual for Mountain Objections on the planet
Highlight Correlation of Microsoft Surface Book and Surface Genius Workstations for Determination













